Annals of the Rheumatic Diseases, 0003-4967

Journal

31 - 40 out of 160Page size: 10
Sort by: Title

Publications

  1. Published

    SAT0719-HPR ''and suddenly you are a person at risk of developing rheumatoid arthritis!’' Different perspectives of individuals on predictive testing –: results of an international qualitative interview study.

    Karim Raza, Rebecca Stack, Gwenda Simons, M Falahee, 15 Jun 2017, In: Annals of the Rheumatic Diseases. 76, p. 1511

    Research output: Contribution to journal › Abstract › peer-review

  2. Published

    SAT0186 Developing predictors of global BILAG treatment response in patients with Lupus Nephritis: more lessons from the Aspreva Lupus Management Study group (ALMS) data

    2 Jun 2020, In: Annals of the Rheumatic Diseases. 79, Suppl 1, p. 1034-1035 2 p.

    Research output: Contribution to journal › Abstract › peer-review

  3. Published

    Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial

    Matthew Morgan, Caroline Savage, Jun 2015, In: Annals of the Rheumatic Diseases. 74, 6, p. 1178-82 5 p.

    Research output: Contribution to journal › Article › peer-review

  4. Accepted/In press

    Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis

    Lorraine Harper, Apr 2020, (Accepted/In press) In: Annals of the Rheumatic Diseases.

    Research output: Contribution to journal › Article › peer-review

  5. Published

    Rituximab abrogates joint destruction in rheumatoid arthritis by inhibiting osteoclastogenesis

    Lorraine Yeo, Dagmar Scheel-Toellner, 1 Jan 2012, In: Annals of the Rheumatic Diseases. 71, 1, p. 108-113 6 p.

    Research output: Contribution to journal › Article

  6. Published

    Risk Communication about NSAIDs plays an important role in RA and OA patient's well-being

    Alison Metcalfe, Collette Clifford, 1 Jan 2004, In: Annals of the Rheumatic Diseases. 63

    Research output: Contribution to journal › Article

  7. Published

    Response to: 'The autoantibody repertoire in periodontitis: a role in the induction of autoimmunity to citrullinated proteins in rheumatoid arthritis? Antibodies against uncitrullinated peptides seem to occur prior to the antibodies to the corresponding citrullinated peptides' by Brink et al

    Paola De Pablo, Thomas Dietrich, Iain Chapple, Michael Milward, Christopher Buckley, Jul 2014, In: Annals of the Rheumatic Diseases. 73, 7, e47.

    Research output: Contribution to journal › Comment/debate › peer-review

  8. E-pub ahead of print

    Response to: Can ultrasound of the major salivary glands assess histopathological changes induced by treatment with rituximab in primary Sjögren's syndrome?

    Benjamin Fisher & Simon Bowman, 13 Apr 2018, In: Annals of the Rheumatic Diseases.

    Research output: Contribution to journal › Article

  9. Published

    Reduction of fatigue in Sjogren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study

    Simon Bowman, John Hamburger, Saaeha Rauz, 29 Nov 2007, In: Annals of the Rheumatic Diseases. 67, 11, p. 1541-1544 4 p.

    Research output: Contribution to journal › Article

  10. Published

    Redefining overweight and obesity in rheumatoid arthritis patients

    Antonios Stavropoulos-Kalinoglou, DO NOT USE Nevill, Joachimina Veldhuijzen van Zanten, Oct 2007, In: Annals of the Rheumatic Diseases. 66, 10, p. 1316-21 6 p.

    Research output: Contribution to journal › Article › peer-review

Previous 1 2 3 4 5 6 7 8 ...16 Next